Cephalon's Nuvigil Will Be Discounted To Provigil, But Not "At A Low Price"
This article was originally published in The Pink Sheet Daily
Executive Summary
Cephalon will encourage patients to switch to follow-on Nuvigil by increasing the Provigil price "dramatically" ahead of generic competition. The company will file the Nuvigil NDA within the next couple of weeks.
You may also be interested in...
Cephalon Will Add 250-Rep Pediatric Sales Force For Modafinil ADHD Launch
The firm plans two launches for early 2006: modafinil for attention deficit/hyperactivity disorder (formerly under the trade name Attenace) and Nuvigil (armodafinil) for sleep disorders. Cephalon has two additional products nearing submission.
Cephalon Will Add 250-Rep Pediatric Sales Force For Modafinil ADHD Launch
The firm plans two launches for early 2006: modafinil for attention deficit/hyperactivity disorder (formerly under the trade name Attenace) and Nuvigil (armodafinil) for sleep disorders. Cephalon has two additional products nearing submission.
Cephalon’s Nuvigil Filing Remains On Schedule For First Quarter
Cephalon's modafinil follow-on Nuvigil (armodafinil) showed statistical significance in each of four pivotal studies intended to support a first-quarter NDA filing, the firm announced Feb. 10